✦ LIBER ✦

Corrigendum to: “Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder” [Eur Urol 2007;52:1204-12]

✍ Scribed by Christopher Chapple; Philip Van Kerrebroeck; Andrea Tubaro; Cornelia Haag-Molkenteller; Hans-Theo Forst; Ute Massow; Joseph Wang; Marina Brodsky

Book ID: 113611455
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 52 KB
Volume: 56
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2009.04.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to: “Clinical Efficacy, Safe

Corrigendum to: “Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder” [Eur Urol 2007;52:1204–12]

✍ Christopher Chapple; Philip Van Kerrebroeck; Andrea Tubaro; Cornelia Haag-Molken 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Clinical Efficacy, Safety, and Tolerabil

Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder

✍ Christopher Chapple; Philip Van Kerrebroeck; Andrea Tubaro; Cornelia Haag-Molken 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 369 KB

e u r o p e a n u r o l o g y 5 2 ( 2 0 0 7 ) 1 2 0 4 -1 2 1 2 a v a i l a b l e a t w w w . s c i e n c e d i r e c t . c o m j o u r n a l h o m e p a g e : w w w . e u r o p e a n u r o l o g y . c o m